Comparative study of once vs. twice daily regimen of double dose of rabeprazole in uncontrolled GERD patients taking usual dose of proton pump inhibitors.
Not Applicable
- Conditions
- Gastro-Esophageal Reflux Disease
- Registration Number
- JPRN-UMIN000022989
- Lead Sponsor
- Keiyu Hospital Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects who have any mental disorders Subjects who have histories of allergy against laperazol Subjects who have serious complications and problems to continue to perform this clinical trial Subjects who are pregnant, possibly pregnant, or feeding her children Subjects who cannot accept an upper GI endoscopic examination Subjects who have two-fold dose of PPI during 4 weeks before the clinical trial starts Subjects who are decided to be unacceptable for this clinical trial by their clinical physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of GERD symptoms,sleep disturbance and QO
- Secondary Outcome Measures
Name Time Method